# CVS HEALTH CORPORATION (CVS) FY2025 Q1 P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2025-01-01 to 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-01, accession number 0000064803-25-000013
- Page: https://plicit.ai/financials/cvs/fy2025-q1-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2025-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2025-01-01 through 2025-03-31. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 94,588,000,000 US dollars
- **Total operating costs**: 91,214,000,000 US dollars
- **Operating income**: 3,374,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 757,000,000 US dollars
- **Income before income tax provision**: 2,617,000,000 US dollars
- **Income tax provision**: 835,000,000 US dollars
- **Net income**: 1,782,000,000 US dollars
- **Products**: 57,669,000,000 US dollars
- **Services**: 3,579,000,000 US dollars
- **Premiums**: 32,820,000,000 US dollars
- **Net investment income**: 520,000,000 US dollars
- **Cost of products sold**: 51,057,000,000 US dollars
- **Health care costs**: 29,135,000,000 US dollars
- **Operating expenses**: 11,022,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $1.78 B; to noncontrolling interests: $3.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2025-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2025-q1-revenue-by-business-segment-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 94,588,000,000 US dollars
- **Total operating costs**: 91,214,000,000 US dollars
- **Operating income**: 3,374,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 757,000,000 US dollars
- **Income before income tax provision**: 2,617,000,000 US dollars
- **Income tax provision**: 835,000,000 US dollars
- **Net income**: 1,782,000,000 US dollars
- **Health Care Benefits**: 34,810,000,000 US dollars
- **Health Services**: 43,462,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 31,912,000,000 US dollars
- **Cost of products sold**: 51,057,000,000 US dollars
- **Health care costs**: 29,135,000,000 US dollars
- **Operating expenses**: 11,022,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 110,184,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Health Care Benefits**: negative 18,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Health Services**: negative 5,352,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Pharmacy & Consumer Wellness**: negative 10,359,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 133,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $1.78 B; to noncontrolling interests: $3.00 M.